Macrophage depletion abates porphyromonas gingivalis-induced alveolar bone resorption in mice

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2349-2362

  Lam, Roselind S ^a   O'Brien Simpson, Neil M ^a   Lenzo, Jason C ^a   Holden, James A ^a   Brammar, Gail C ^a   Walsh, Katrina A ^a   McNaughtan, Judith E ^a   Rowler, Dennis K ^a   Van Rooijen, Nico ^b   Reynolds, Eric C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD206 ANTIGEN; CD86 ANTIGEN; CLODRONIC ACID; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; LIPOSOME; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA; CYTOKINE;

ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; GRAM NEGATIVE INFECTION; LYMPH NODE; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PERIODONTITIS; PERITONEUM MACROPHAGE; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; ANIMAL; BACTEROIDACEAE INFECTION; IMMUNOLOGY; PATHOLOGY;

ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDACEAE INFECTIONS; CYTOKINES; MACROPHAGES; MICE; MICE, INBRED BALB C; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

EID: 84907033631     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400853     Document Type: Article

References (106)

1. Chapple, C. C., M. Srivastava, and N. Hunter. 1998. Failure of macrophage activation in destructive periodontal disease. J. Pathol. 186: 281-286.
2. Page, R. C. 1991. The role of inflammatory mediators in the pathogenesis of periodontal disease. J. Periodontal Res. 26: 230-242.
3. Eke, P. I., B. A. Dye, L. Wei, G. O. Thornton-Evans, and R. J. Genco, CDC Periodontal Disease Surveillance workgroup: James Beck (University of North Carolina, Chapel Hill, USA), Gordon Douglass (Past President, American Academy of Periodontology), Roy Page (University of Washin. 2012. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91: 914-920.
4. Haffajee, A. D., M. A. Cugini, A. Tanner, R. P. Pollack, C. Smith, R. L. Kent, Jr., and S. S. Socransky. 1998. Subgingival microbiota in healthy, wellmaintained elder and periodontitis subjects. J. Clin. Periodontol. 25: 346-353.
5. Lamont, R. J., and H. F. Jenkinson. 1998. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62: 1244-1263.
6. Komiya, A., T. Kato, T. Nakagawa, A. Saito, J. Takahashi, S. Yamada, and K. Okuda. 2000. A rapid DNA probe method for detection of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. J. Periodontol. 71: 760-767.
7. Socransky, S. S., A. D. Haffajee, M. A. Cugini, C. Smith, and R. L. Kent, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134-144.
8. Darveau, R. P., G. Hajishengallis, and M. A. Curtis. 2012. Porphyromonas gingivalis as a potential community activist for disease. J. Dent. Res. 91: 816-820.
9. Hajishengallis, G., S. Liang, M. A. Payne, A. Hashim, R. Jotwani, M. A. Eskan, M. L. McIntosh, A. Alsam, K. L. Kirkwood, J. D. Lambris, et al. 2011. Lowabundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10: 497-506.
10. Mercado, F., R. I. Marshall, A. C. Klestov, and P. M. Bartold. 2000. Is there a relationship between rheumatoid arthritis and periodontal disease? J. Clin. Periodontol. 27: 267-272.
11. Michaud, D. S., K. Joshipura, E. Giovannucci, and C. S. Fuchs. 2007. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl. Cancer Inst. 99: 171-175.
12. Miyakawa, H., K. Honma, M. Qi, and H. K. Kuramitsu. 2004. Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J. Periodontal Res. 39: 1-9.
13. Offenbacher, S., H. L. Jared, P. G. O'Reilly, S. R. Wells, G. E. Salvi, H. P. Lawrence, S. S. Socransky, and J. D. Beck. 1998. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann. Periodontol. 3: 233-250.
14. Pucher, J., and J. Stewart. 2004. Periodontal disease and diabetes mellitus. Curr. Diab. Rep. 4: 46-50.
15. Gemmell, E., G. B. McHugh, D. A. Grieco, and G. J. Seymour. 2001. Costimulatory molecules in human periodontal disease tissues. J. Periodontal Res. 36: 92-100.
16. Gordon, S. 1998. The role of the macrophage in immune regulation. Res. Immunol. 149: 685-688.
17. Lappin, D. F., M. Kjeldsen, L. Sander, and D. F. Kinane. 2000. Inducible nitric oxide synthase expression in periodontitis. J. Periodontal Res. 35: 369-373.
18. Kawashima, N., and P. Stashenko. 1999. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch. Oral Biol. 44: 55-66.
19. Matsuki, Y., T. Yamamoto, and K. Hara. 1992. Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunology 76: 42-47.
20. Prabhu, A., B. S. Michalowicz, and A. Mathur. 1996. Detection of local and systemic cytokines in adult periodontitis. J. Periodontol. 67: 515-522.
21. Preiss, D. S., and J. Meyle. 1994. Interleukin-1 beta concentration of gingival crevicular fluid. J. Periodontol. 65: 423-428.
22. Jandinski, J. J., P. Stashenko, L. S. Feder, C. C. Leung, W. J. Peros, J. E. Rynar, and M. J. Deasy. 1991. Localization of interleukin-1 beta in human periodontal tissue. J. Periodontol. 62: 36-43.
23. Offenbacher, S., V. Katz, G. Fertik, J. Collins, D. Boyd, G. Maynor, R. McKaig, and J. Beck. 1996. Periodontal infection as a possible risk factor for preterm low birth weight. J. Periodontol. 67(10, Suppl.)1103-1113.
24. Offenbacher, S., B. M. Odle, and T. E. Van Dyke. 1986. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J. Periodontal Res. 21: 101-112.
25. Richards, D., and R. B. Rutherford. 1988. The effects of interleukin 1 on collagenolytic activity and prostaglandin-E secretion by human periodontal-ligament and gingival fibroblast. Arch. Oral Biol. 33: 237-243.
26. Bertolini, D R., G. E. Nedwin, T. S. Bringman, D. D. Smith, and G. R. Mundy. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516-518.
27. Heath, J. K., J. Saklatvala, M. C. Meikle, S. J. Atkinson, and J. J. Reynolds. 1985. Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif. Tissue Int. 37: 95-97.
28. Merkel, K. D., J. M. Erdmann, K. P. McHugh, Y. Abu-Amer, F. P. Ross, and S. L. Teitelbaum. 1999. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am. J. Pathol. 154: 203-210.
29. Hanazawa, S., A. Takeshita, S. Amano, T. Semba, T. Nirazuka, H. Katoh, and S. Kitano. 1993. Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268: 9526-9532.
30. Mathur, A., B. Michalowicz, M. Castillo, and D. Aeppli. 1996. Interleukin-1 alpha, interleukin-8 and interferon-alpha levels in gingival crevicular fluid. J. Periodontal Res. 31: 489-495.
31. Cavaillon, J. M. 1994. Cytokines and macrophages. Biomed. Pharmacother. 48: 445-453.
32. Tonetti, M. S. 1997. Molecular factors associated with compartmentalization of gingival immune responses and transepithelial neutrophil migration. J. Periodontal Res. 32: 104-109.
33. Yu, X., H. N. Antoniades, and D. T. Graves. 1993. Expression of monocyte chemoattractant protein 1 in human inflamed gingival tissues. Infect. Immun. 61: 4622-4628.
34. Adamopoulos, I. E., A. Sabokbar, B. P. Wordsworth, A. Carr, D. J. Ferguson, and N. A. Athanasou. 2006. Synovial fluid macrophages are capable of osteoclast formation and resorption. J. Pathol. 208: 35-43.
35. Chambers, T. J. 2000. Regulation of the differentiation and function of osteoclasts. J. Pathol. 192: 4-13.
36. Lassus, J., J. Salo, W. A. Jiranek, S. Santavirta, J. Nevalainen, M. Matucci-Cerinic, P. Horák, and Y. Konttinen. 1998. Macrophage activation results in bone resorption. Clin. Orthop. Relat. Res. (352):7-15.
37. Birkedal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28: 500-510.
38. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
39. Mantovani, A., A. Sica, and M. Locati. 2005. Macrophage polarization comes of age. Immunity 23: 344-346.
40. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
41. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544.
42. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
43. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73: 209-212.
44. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565.
45. Byrne, S. J., S. G. Dashper, I. B. Darby, G. G. Adams, B. Hoffmann, and E. C. Reynolds. 2009. Progression of chronic periodontitis can be predicted by the levels of Porphyromonas gingivalis and Treponema denticola in subgingival plaque. Oral Microbiol. Immunol. 24: 469-477.
46. Greenstein, G., and I. Lamster. 2000. Changing periodontal paradigms: therapeutic implications. Int. J. Periodontics Restorative Dent. 20: 336-357.
47. O-Brien-Simpson, N. M., P. D. Veith, S. G. Dashper, and E. C. Reynolds. 2003. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire. Curr. Protein Pept. Sci. 4: 409-426.
48. O'Brien-Simpson, N. M., R. D. Pathirana, R. A. Paolini, Y. Y. Chen, P. D. Veith, V. Tam, N. Ally, R. N. Pike, and E. C. Reynolds. 2005. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol. 175: 3980-3989.
49. Pathirana, R. D., N. M. O'Brien-Simpson, G. C. Brammar, N. Slakeski, and E. C. Reynolds. 2007. Kgp and RgpB, but not RgpA, are important for Porphyromonas gingivalis virulence in the murine periodontitis model. Infect. Immun. 75: 1436-1442.
50. O'Brien-Simpson, N. M., R. D. Pathirana, G. D. Walker, and E. C. Reynolds. 2009. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect. Immun. 77: 1246-1261.
51. Pathirana, R. D., N. M. O'Brien-Simpson, and E. C. Reynolds. 2010. Host immune responses to Porphyromonas gingivalis antigens. Periodontol. 2000 52: 218-237.
52. Nichols, F. C., W. J. Housley, C. A. O'Conor, T. Manning, S. Wu, and R. B. Clark. 2009. Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity. Am. J. Pathol. 175: 2430-2438.
53. Nichols, F C., X. Yao, B. Bajrami, J. Downes, S. M. Finegold, E. Knee, J. J. Gallagher, W. J. Housley, and R. B. Clark. 2011. Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues. PLoS ONE 6: e16771.
54. Nichols, F. C., B. Riep, J. Mun, M. D. Morton, T. Kawai, F. E. Dewhirst, and M. B. Smith. 2006. Structures and biological activities of novel phosphatidylethanolamine lipids of Porphyromonas gingivalis. J. Lipid Res. 47: 844-853.
55. Nichols, T. C., T. H. Fischer, E. N. Deliargyris, and A. S. Baldwin, Jr. 2001. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis. Ann. Periodontol. 6: 20-29.
56. Bischof, R. J., D. Zafiropoulos, J. A. Hamilton, and I. K. Campbell. 2000. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol. 119: 361-367.
57. Isomäki, P., and J. Punnonen. 1997. Pro-and anti-inflammatory cytokines in rheumatoid arthritis. Ann. Med. 29: 499-507.
58. Kinne, R. W., R. Bräuer, B. Stuhlmüller, E. Palombo-Kinne, and G. R. Burmester. 2000. Macrophages in rheumatoid arthritis. Arthritis Res. 2: 189-202.
59. Synderman, R., and G. A. McCarty. 1982. Analogous mechanism of tissue destruction in rheumatoid arthritis and periodontal disease. In Host-Parasite Interactions in Periodontal Diseases. R. J. Genco, and S. E. Mergenhagen, eds. American Society for Microbiology, Washington, D.C., p. 354-362.
60. Barrera, P., A. Blom, P. L. van Lent, L. van Bloois, J. H. Beijnen, N. van Rooijen, M. C. de Waal Malefijt, L. B. van de Putte, G. Storm, and W. B. van den Berg. 2000. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 43: 1951-1959.
61. Bauer, D., S. Mrzyk, N. Van Rooijen, K. P. Steuhl, and A. Heiligenhaus. 2001. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp. Eye Res. 72: 261-269.
62. Buiting, A. M. J., F. Zhou, J. A. J. Bakker, N. van Rooijen, and L. Huang. 1996. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach. J. Immunol. Methods 192: 55-62.
63. Naito, M., S. Umeda, T. Yamamoto, H. Moriyama, H. Umezu, G. Hasegawa, H. Usuda, L. D. Shultz, and K. Takahashi. 1996. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J. Leukoc. Biol. 59: 133-138.
64. Russell, R. G., and M. J. Rogers. 1999. Bisphosphonates: from the laboratory to the clinic and back again. Bone 25: 97-106.
65. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
66. Griffen, A. L., S. R. Lyons, M. R. Becker, M. L. Moeschberger, and E. J. Leys. 1999. Porphyromonas gingivalis strain variability and periodontitis. J. Clin. Microbiol. 37: 4028-4033.
67. Orth, R. K., N. M. O'Brien-Simpson, S. G. Dashper, and E. C. Reynolds. 2011. Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol. Oral Microbiol. 26: 229-240.
68. Rajapakse, P. S., N. M. O'Brien-Simpson, N. Slakeski, B. Hoffmann, and E. C. Reynolds. 2002. Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model. Infect. Immun. 70: 2480-2486.
69. McKee, A. S., A. S. McDermid, A. Baskerville, A. B. Dowsett, D. C. Ellwood, and P. D. Marsh. 1986. Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect. Immun. 52: 349-355.
70. Slots, J. 1982. Importance of black pigmented Bacteroides in human periodontal disease. In Host-Parasite Interactions in Periodontal Diseases. R. J. Genco, and S. E. Mergenhausen, eds. American Society for Microbiology,Washington, D.C., p. 27-45.
71. O'Brien-Simpson, N. M., C. L. Black, P. S. Bhogal, S. M. Cleal, N. Slakeski, T. J. Higgins, and E. C. Reynolds. 2000. Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinaseadhesin complex of Porphyromonas gingivalis in adult periodontitis. Infect. Immun. 68: 2704-2712.
72. Pathirana, R. D., N. M. O'Brien-Simpson, P. D. Veith, P. F. Riley, and E. C. Reynolds. 2006. Characterization of proteinase-adhesin complexes of Porphyromonas gingivalis. Microbiology 152: 2381-2394.
73. Baker, P. J., R. T. Evans, and D. C. Roopenian. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39: 1035-1040.
74. Bancroft, J. D., and A. Stevens. 1990. Theory and Practice of Histological Techniques. Churchill Livingstone, Edinburgh, U.K.
75. Nadkarni, M. A., F. E. Martin, N. A. Jacques, and N. Hunter. 2002. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266.
76. Gaetti-Jardim, E., Jr., S. L. Marcelino, A. C. Feitosa, G. A. Romito, and M. J. Avila-Campos. 2009. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J. Med. Microbiol. 58: 1568-1575.
77. Jouvin-Marche, E., M. G. Morgado, C. Leguern, D. Voegtle, F. Bonhomme, and P. A. Cazenave. 1989. The mouse Igh-1a and Igh-1β H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 29: 92-97.
78. Martin, R. M., J. L. Brady, and A. M. Lew. 1998. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212: 187-192.
79. Morgado, M. G., P. Cam, C. Gris-Liebe, P. A. Cazenave, and E. Jouvin-Marche. 1989. Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. EMBO J. 8: 3245-3251.
80. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11: 805-815.
81. Leenen, P. J., M. F. de Bruijn, J. S. A. Voerman, P. A. Campbell, and W. van Ewijk. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174: 5-19.
82. Roscic-Mrkic, B., R. A. Schwendener, B. Odermatt, A. Zuniga, J. Pavlovic, M. A. Billeter, and R. Cattaneo. 2001. Roles of macrophages in measles virus infection of genetically modified mice. J. Virol. 75: 3343-3351.
83. Frith, J. C., J. Mönkkönen, S. Auriola, H. Mönkkönen, and M. J. Rogers. 2001. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum. 44: 2201-2210.
84. Bohn, E., E. Schmitt, C. Bielfeldt, A. Noll, R. Schulte, and I. B. Autenrieth. 1998. Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains. Infect. Immun. 66: 2213-2220.
85. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155: 2515-2524.
86. Evans, R. T., B. Klausen, N. S. Ramamurthy, L. M. Golub, C. Sfintescu, and R. J. Genco. 1992. Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch. Oral Biol. 37: 813-819.
87. Mooney, J., and D. F. Kinane. 1997. Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status. Oral Microbiol. Immunol. 12: 112-116.
88. Leenen, P. J., K. Radosević, J. S. Voerman, B. Salomon, N. van Rooijen, D. Klatzmann, and W. van Ewijk. 1998. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J. Immunol. 160: 2166-2173.
89. Biedermann, T., S. Zimmermann, H. Himmelrich, A. Gumy, O. Egeter, A. K. Sakrauski, I. Seegmüller, H. Voigt, P. Launois, A. D. Levine, et al. 2001. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2: 1054-1060.
90. Liu, T., N. van Rooijen, and D. J. Tracey. 2000. Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain 86: 25-32.
91. Parajuli, P., R. L. Mosley, V. Pisarev, J. Chavez, A. Ulrich, M. Varney, R. K. Singh, and J. E. Talmadge. 2001. Flt3 ligand and granulocytemacrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets. Exp. Hematol. 29: 1185-1193.
92. Qi, H., V. Popov, and L. Soong. 2001. Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J. Immunol. 167: 4534-4542.
93. Reid, S. D., G. Penna, and L. Adorini. 2000. The control of T cell responses by dendritic cell subsets. Curr. Opin. Immunol. 12: 114-121.
94. Wesa, A. K., and A. Galy. 2001. IL-1 beta induces dendritic cells to produce IL-12. Int. Immunol. 13: 1053-1061.
95. Benoit, M., B. Desnues, and J. L. Mege. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181: 3733-3739.
96. Ho, V. W., and L. M. Sly. 2009. Derivation and characterization of murine alternatively activated (M2) macrophages. Methods Mol. Biol. 531: 173-185.
97. Hamrah, P., Y. Liu, Q. Zhang, and M. R. Dana. 2003. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest. Ophthalmol. Vis. Sci. 44: 581-589.
98. Jin, X., H. Ishii, Z. Bai, T. Itokazu, and T. Yamashita. 2012. Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL/6 mice. PLoS ONE 7: e41892.
99. Barth, M. W., J. A. Hendrzak, M. J. Melnicoff, and P. S. Morahan. 1995. Review of the macrophage disappearance reaction. J. Leukoc. Biol. 57: 361-367.
100. Tonetti, M. S., M. A. Imboden, L. Gerber, N. P. Lang, J. Laissue, and C. Mueller. 1994. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect. Immun. 62: 4005-4014.
101. Chavrier, C., M. L. Couble, D. Hartmann, J. A. Grimaud, and H. Magloire. 1987. Immunohistochemical study of types I, III and IV collagen in fibrosis of diseased gingiva during chronic periodontitis: a light and electron microscopic study. J. Periodontal Res. 22: 29-36.
102. Larjava, H., M. Sandberg, and E. Vuorio. 1989. Altered distribution of type I collagen mRNA in periodontal disease. J. Periodontal Res. 24: 171-177.
103. Larjava, H., V. J. Uitto, M. Haapasalo, J. Heino, and M. Vuento. 1987. Fibronectin fragmentation induced by dental plaque and Bacteroides gingivalis. Scand. J. Dent. Res. 95: 308-314.
104. Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167: 2887-2894.
105. Chaves, E. S., M. K. Jeffcoat, C. C. Ryerson, and B. Snyder. 2000. Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy. J. Clin. Periodontol. 27: 897-903.
106. Jiao, Y., Y. Darzi, K. Tawaratsumida, J. T. Marchesan, M. Hasegawa, H. Moon, G. Y. Chen, G. Núñez, W. V. Giannobile, J. Raes, and N. Inohara. 2013. Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. Cell Host Microbe 13: 595-601.